Global Recombinant Follicle Stimulating Hormone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 91

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the "contaminants" seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.

According to our (Global Info Research) latest study, the global Recombinant Follicle Stimulating Hormone market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Recombinant Follicle Stimulating Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Recombinant Follicle Stimulating Hormone market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Recombinant Follicle Stimulating Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Recombinant Follicle Stimulating Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029
Global Recombinant Follicle Stimulating Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Follicle Stimulating Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Follicle Stimulating Hormone market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Serono, MSD, Techwell, GenSci and Gedeon Richter and  etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Recombinant Follicle Stimulating Hormone market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    75IU
    150IU
    Others

Market segment by Application
    Infertility Treatment
    Assisted Reproductive Technology

Major players covered
    Merck Serono
    MSD
    Techwell
    GenSci
    Gedeon Richter
    Teva

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Follicle Stimulating Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Follicle Stimulating Hormone, with price, sales, revenue and global market share of Recombinant Follicle Stimulating Hormone from 2018 to 2023.
Chapter 3, the Recombinant Follicle Stimulating Hormone competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Follicle Stimulating Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Follicle Stimulating Hormone market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Follicle Stimulating Hormone.
Chapter 14 and 15, to describe Recombinant Follicle Stimulating Hormone sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Recombinant Follicle Stimulating Hormone
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Recombinant Follicle Stimulating Hormone Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 75IU
        1.3.3 150IU
        1.3.4 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Recombinant Follicle Stimulating Hormone Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Infertility Treatment
        1.4.3 Assisted Reproductive Technology
    1.5 Global Recombinant Follicle Stimulating Hormone Market Size & Forecast
        1.5.1 Global Recombinant Follicle Stimulating Hormone Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Recombinant Follicle Stimulating Hormone Sales Quantity (2018-2029)
        1.5.3 Global Recombinant Follicle Stimulating Hormone Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Merck Serono
        2.1.1 Merck Serono Details
        2.1.2 Merck Serono Major Business
        2.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
        2.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Merck Serono Recent Developments/Updates
    2.2 MSD
        2.2.1 MSD Details
        2.2.2 MSD Major Business
        2.2.3 MSD Recombinant Follicle Stimulating Hormone Product and Services
        2.2.4 MSD Recombinant Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 MSD Recent Developments/Updates
    2.3 Techwell
        2.3.1 Techwell Details
        2.3.2 Techwell Major Business
        2.3.3 Techwell Recombinant Follicle Stimulating Hormone Product and Services
        2.3.4 Techwell Recombinant Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Techwell Recent Developments/Updates
    2.4 GenSci
        2.4.1 GenSci Details
        2.4.2 GenSci Major Business
        2.4.3 GenSci Recombinant Follicle Stimulating Hormone Product and Services
        2.4.4 GenSci Recombinant Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 GenSci Recent Developments/Updates
    2.5 Gedeon Richter
        2.5.1 Gedeon Richter Details
        2.5.2 Gedeon Richter Major Business
        2.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
        2.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Gedeon Richter Recent Developments/Updates
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Recombinant Follicle Stimulating Hormone Product and Services
        2.6.4 Teva Recombinant Follicle Stimulating Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Teva Recent Developments/Updates

3 Competitive Environment: Recombinant Follicle Stimulating Hormone by Manufacturer
    3.1 Global Recombinant Follicle Stimulating Hormone Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Recombinant Follicle Stimulating Hormone Revenue by Manufacturer (2018-2023)
    3.3 Global Recombinant Follicle Stimulating Hormone Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Recombinant Follicle Stimulating Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Recombinant Follicle Stimulating Hormone Manufacturer Market Share in 2022
        3.4.2 Top 6 Recombinant Follicle Stimulating Hormone Manufacturer Market Share in 2022
    3.5 Recombinant Follicle Stimulating Hormone Market: Overall Company Footprint Analysis
        3.5.1 Recombinant Follicle Stimulating Hormone Market: Region Footprint
        3.5.2 Recombinant Follicle Stimulating Hormone Market: Company Product Type Footprint
        3.5.3 Recombinant Follicle Stimulating Hormone Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Recombinant Follicle Stimulating Hormone Market Size by Region
        4.1.1 Global Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2018-2029)
        4.1.2 Global Recombinant Follicle Stimulating Hormone Consumption Value by Region (2018-2029)
        4.1.3 Global Recombinant Follicle Stimulating Hormone Average Price by Region (2018-2029)
    4.2 North America Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029)
    4.3 Europe Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029)
    4.4 Asia-Pacific Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029)
    4.5 South America Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029)
    4.6 Middle East and Africa Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2029)
    5.2 Global Recombinant Follicle Stimulating Hormone Consumption Value by Type (2018-2029)
    5.3 Global Recombinant Follicle Stimulating Hormone Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2029)
    6.2 Global Recombinant Follicle Stimulating Hormone Consumption Value by Application (2018-2029)
    6.3 Global Recombinant Follicle Stimulating Hormone Average Price by Application (2018-2029)

7 North America
    7.1 North America Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2029)
    7.2 North America Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2029)
    7.3 North America Recombinant Follicle Stimulating Hormone Market Size by Country
        7.3.1 North America Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2018-2029)
        7.3.2 North America Recombinant Follicle Stimulating Hormone Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2029)
    8.2 Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2029)
    8.3 Europe Recombinant Follicle Stimulating Hormone Market Size by Country
        8.3.1 Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2018-2029)
        8.3.2 Europe Recombinant Follicle Stimulating Hormone Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size by Region
        9.3.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2029)
    10.2 South America Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2029)
    10.3 South America Recombinant Follicle Stimulating Hormone Market Size by Country
        10.3.1 South America Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2018-2029)
        10.3.2 South America Recombinant Follicle Stimulating Hormone Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Recombinant Follicle Stimulating Hormone Market Size by Country
        11.3.1 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Recombinant Follicle Stimulating Hormone Market Drivers
    12.2 Recombinant Follicle Stimulating Hormone Market Restraints
    12.3 Recombinant Follicle Stimulating Hormone Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Recombinant Follicle Stimulating Hormone and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Recombinant Follicle Stimulating Hormone
    13.3 Recombinant Follicle Stimulating Hormone Production Process
    13.4 Recombinant Follicle Stimulating Hormone Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Recombinant Follicle Stimulating Hormone Typical Distributors
    14.3 Recombinant Follicle Stimulating Hormone Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Follicle Stimulating Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Recombinant Follicle Stimulating Hormone Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Merck Serono Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Serono Major Business
    Table 5. Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
    Table 6. Merck Serono Recombinant Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Merck Serono Recent Developments/Updates
    Table 8. MSD Basic Information, Manufacturing Base and Competitors
    Table 9. MSD Major Business
    Table 10. MSD Recombinant Follicle Stimulating Hormone Product and Services
    Table 11. MSD Recombinant Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. MSD Recent Developments/Updates
    Table 13. Techwell Basic Information, Manufacturing Base and Competitors
    Table 14. Techwell Major Business
    Table 15. Techwell Recombinant Follicle Stimulating Hormone Product and Services
    Table 16. Techwell Recombinant Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Techwell Recent Developments/Updates
    Table 18. GenSci Basic Information, Manufacturing Base and Competitors
    Table 19. GenSci Major Business
    Table 20. GenSci Recombinant Follicle Stimulating Hormone Product and Services
    Table 21. GenSci Recombinant Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. GenSci Recent Developments/Updates
    Table 23. Gedeon Richter Basic Information, Manufacturing Base and Competitors
    Table 24. Gedeon Richter Major Business
    Table 25. Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
    Table 26. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Gedeon Richter Recent Developments/Updates
    Table 28. Teva Basic Information, Manufacturing Base and Competitors
    Table 29. Teva Major Business
    Table 30. Teva Recombinant Follicle Stimulating Hormone Product and Services
    Table 31. Teva Recombinant Follicle Stimulating Hormone Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Teva Recent Developments/Updates
    Table 33. Global Recombinant Follicle Stimulating Hormone Sales Quantity by Manufacturer (2018-2023) & (K Doses)
    Table 34. Global Recombinant Follicle Stimulating Hormone Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 35. Global Recombinant Follicle Stimulating Hormone Average Price by Manufacturer (2018-2023) & (USD/Dose)
    Table 36. Market Position of Manufacturers in Recombinant Follicle Stimulating Hormone, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 37. Head Office and Recombinant Follicle Stimulating Hormone Production Site of Key Manufacturer
    Table 38. Recombinant Follicle Stimulating Hormone Market: Company Product Type Footprint
    Table 39. Recombinant Follicle Stimulating Hormone Market: Company Product Application Footprint
    Table 40. Recombinant Follicle Stimulating Hormone New Market Entrants and Barriers to Market Entry
    Table 41. Recombinant Follicle Stimulating Hormone Mergers, Acquisition, Agreements, and Collaborations
    Table 42. Global Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2018-2023) & (K Doses)
    Table 43. Global Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2024-2029) & (K Doses)
    Table 44. Global Recombinant Follicle Stimulating Hormone Consumption Value by Region (2018-2023) & (USD Million)
    Table 45. Global Recombinant Follicle Stimulating Hormone Consumption Value by Region (2024-2029) & (USD Million)
    Table 46. Global Recombinant Follicle Stimulating Hormone Average Price by Region (2018-2023) & (USD/Dose)
    Table 47. Global Recombinant Follicle Stimulating Hormone Average Price by Region (2024-2029) & (USD/Dose)
    Table 48. Global Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2023) & (K Doses)
    Table 49. Global Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2024-2029) & (K Doses)
    Table 50. Global Recombinant Follicle Stimulating Hormone Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Global Recombinant Follicle Stimulating Hormone Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Global Recombinant Follicle Stimulating Hormone Average Price by Type (2018-2023) & (USD/Dose)
    Table 53. Global Recombinant Follicle Stimulating Hormone Average Price by Type (2024-2029) & (USD/Dose)
    Table 54. Global Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2023) & (K Doses)
    Table 55. Global Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2024-2029) & (K Doses)
    Table 56. Global Recombinant Follicle Stimulating Hormone Consumption Value by Application (2018-2023) & (USD Million)
    Table 57. Global Recombinant Follicle Stimulating Hormone Consumption Value by Application (2024-2029) & (USD Million)
    Table 58. Global Recombinant Follicle Stimulating Hormone Average Price by Application (2018-2023) & (USD/Dose)
    Table 59. Global Recombinant Follicle Stimulating Hormone Average Price by Application (2024-2029) & (USD/Dose)
    Table 60. North America Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2023) & (K Doses)
    Table 61. North America Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2024-2029) & (K Doses)
    Table 62. North America Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2023) & (K Doses)
    Table 63. North America Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2024-2029) & (K Doses)
    Table 64. North America Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2018-2023) & (K Doses)
    Table 65. North America Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2024-2029) & (K Doses)
    Table 66. North America Recombinant Follicle Stimulating Hormone Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. North America Recombinant Follicle Stimulating Hormone Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2023) & (K Doses)
    Table 69. Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2024-2029) & (K Doses)
    Table 70. Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2023) & (K Doses)
    Table 71. Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2024-2029) & (K Doses)
    Table 72. Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2018-2023) & (K Doses)
    Table 73. Europe Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2024-2029) & (K Doses)
    Table 74. Europe Recombinant Follicle Stimulating Hormone Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Recombinant Follicle Stimulating Hormone Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2023) & (K Doses)
    Table 77. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2024-2029) & (K Doses)
    Table 78. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2023) & (K Doses)
    Table 79. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2024-2029) & (K Doses)
    Table 80. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2018-2023) & (K Doses)
    Table 81. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2024-2029) & (K Doses)
    Table 82. Asia-Pacific Recombinant Follicle Stimulating Hormone Consumption Value by Region (2018-2023) & (USD Million)
    Table 83. Asia-Pacific Recombinant Follicle Stimulating Hormone Consumption Value by Region (2024-2029) & (USD Million)
    Table 84. South America Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2023) & (K Doses)
    Table 85. South America Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2024-2029) & (K Doses)
    Table 86. South America Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2023) & (K Doses)
    Table 87. South America Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2024-2029) & (K Doses)
    Table 88. South America Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2018-2023) & (K Doses)
    Table 89. South America Recombinant Follicle Stimulating Hormone Sales Quantity by Country (2024-2029) & (K Doses)
    Table 90. South America Recombinant Follicle Stimulating Hormone Consumption Value by Country (2018-2023) & (USD Million)
    Table 91. South America Recombinant Follicle Stimulating Hormone Consumption Value by Country (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2018-2023) & (K Doses)
    Table 93. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Type (2024-2029) & (K Doses)
    Table 94. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2018-2023) & (K Doses)
    Table 95. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Application (2024-2029) & (K Doses)
    Table 96. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2018-2023) & (K Doses)
    Table 97. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity by Region (2024-2029) & (K Doses)
    Table 98. Middle East & Africa Recombinant Follicle Stimulating Hormone Consumption Value by Region (2018-2023) & (USD Million)
    Table 99. Middle East & Africa Recombinant Follicle Stimulating Hormone Consumption Value by Region (2024-2029) & (USD Million)
    Table 100. Recombinant Follicle Stimulating Hormone Raw Material
    Table 101. Key Manufacturers of Recombinant Follicle Stimulating Hormone Raw Materials
    Table 102. Recombinant Follicle Stimulating Hormone Typical Distributors
    Table 103. Recombinant Follicle Stimulating Hormone Typical Customers
List of Figures
    Figure 1. Recombinant Follicle Stimulating Hormone Picture
    Figure 2. Global Recombinant Follicle Stimulating Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Type in 2022
    Figure 4. 75IU Examples
    Figure 5. 150IU Examples
    Figure 6. Others Examples
    Figure 7. Global Recombinant Follicle Stimulating Hormone Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Application in 2022
    Figure 9. Infertility Treatment Examples
    Figure 10. Assisted Reproductive Technology Examples
    Figure 11. Global Recombinant Follicle Stimulating Hormone Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Recombinant Follicle Stimulating Hormone Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Recombinant Follicle Stimulating Hormone Sales Quantity (2018-2029) & (K Doses)
    Figure 14. Global Recombinant Follicle Stimulating Hormone Average Price (2018-2029) & (USD/Dose)
    Figure 15. Global Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Recombinant Follicle Stimulating Hormone by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Recombinant Follicle Stimulating Hormone Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Recombinant Follicle Stimulating Hormone Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Recombinant Follicle Stimulating Hormone Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Recombinant Follicle Stimulating Hormone Average Price by Type (2018-2029) & (USD/Dose)
    Figure 30. Global Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Recombinant Follicle Stimulating Hormone Average Price by Application (2018-2029) & (USD/Dose)
    Figure 33. North America Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Recombinant Follicle Stimulating Hormone Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Recombinant Follicle Stimulating Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Recombinant Follicle Stimulating Hormone Market Drivers
    Figure 74. Recombinant Follicle Stimulating Hormone Market Restraints
    Figure 75. Recombinant Follicle Stimulating Hormone Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Recombinant Follicle Stimulating Hormone in 2022
    Figure 78. Manufacturing Process Analysis of Recombinant Follicle Stimulating Hormone
    Figure 79. Recombinant Follicle Stimulating Hormone Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva

Related Reports

Global Recombinant Follicle Stimulating Hormone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Recombinant Follicle Stimulating Hormone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 30 Jan 2021

date Pharma & Healthcare

The Recombinant Follicle Stimulating Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Recombinant Follicle Stimulating Hormone Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Recombinant Follicle Stimulating Hormone Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 15 Jan 2022

date Pharma & Healthcare

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2023-2029

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2023-2029

date 03 Mar 2023

date Pharma & Healthcare

The global Recombinant Follicle Stimulating Hormone market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Recombinant Follicle Stimulating Hormone Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Recombinant Follicle Stimulating Hormone Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Follicle Stimulating Hormone market size was valued at USD 1075.9 million in 2023 and is forecast to a readjusted size of USD 1550.5 million by 2030 with a CAGR of 5.4% during review period.

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Recombinant Follicle Stimulating Hormone market size is expected to reach $ 1550.5 million by 2030, rising at a market growth of 5.4% CAGR during the forecast period (2024-2030).

Product Tags

recombinant follicle stimulating hormone

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>